Quantitative analysis of cell-free DNA in ovarian cancer
Authors:
Open Access
- 30 September 2015
- journal article
- Published by Spandidos Publications in Oncology Letters
- Vol. 10 (6) , 3478-3482
Abstract
The aim of the present study was to investigate the association between cell-free DNA (cf-DNA) levels and clinicopathological characteristics of patients with ovarian cancer using a branched DNA (bDNA) technique, and to determine the value of quantitative cf-DNA detection in assisting with the diagnosis of ovarian cancer. Serum specimens were collected from 36 patients with ovarian cancer on days 1, 3 and 7 following surgery, and additional serum samples were also collected from 22 benign ovarian tumor cases, and 19 healthy, non-cancerous ovaries. bDNA techniques were used to detect serum cf-DNA concentrations. All data were analyzed using SPSS version 18.0. The cf-DNA levels were significantly increased in the ovarian cancer group compared with those of the benign ovarian tumor group and healthy ovarian group (P<0.01). Furthermore, cf-DNA levels were significantly increased in stage III and IV ovarian cancer compared with those of stages I and II (P<0.01). In addition, cf-DNA levels were significantly increased on the first day post-surgery (P<0.01), and subsequently demonstrated a gradual decrease. In the ovarian cancer group, the area under the receiver operating characteristic curve of cf-DNA and the sensitivity were 0.917 and 88.9%, respectively, which was higher than those of cancer antigen 125 (0.724, 75%) and human epididymis protein 4 (0.743, 80.6%). There was a correlation between the levels of serum cf-DNA and the occurrence and development of ovarian cancer in the patients evaluated. bDNA techniques possessed higher sensitivity and specificity than other methods for the detection of serum cf-DNA in patients exhibiting ovarian cancer, and bDNA techniques are more useful for detecting cf-DNA than other factors. Thus, the present study demonstrated the potential value for the use of bDNA as an adjuvant diagnostic method for ovarian cancer.Keywords
This publication has 26 references indexed in Scilit:
- Ovarian Cancer in Iranian Women, a Trend Analysis of Mortality and IncidenceAsian Pacific Journal of Cancer Prevention, 2015
- Advances in Tumor Screening, Imaging, and Avatar Technologies for High-Grade Serous Ovarian CancerFrontiers in Oncology, 2014
- Use of CA125 and HE4 Serum Markers to Predict Ovarian Cancer in Elevated-Risk WomenCancer Epidemiology, Biomarkers & Prevention, 2014
- Comparison of serum human epididymis protein 4 and carbohydrate antigen 125 as markers in ovarian cancer: A meta-analysisMolecular and Clinical Oncology, 2014
- Long-term survival of young women receiving fertility-sparing surgery for ovarian cancer in comparison with those undergoing radical surgeryBritish Journal of Cancer, 2011
- Incidence, trends and morphology of ovarian cancer in Karachi (1995-2002).2011
- DNA-based assay for EPHB6 expression in breast carcinoma cells as a potential diagnostic test for detecting tumor cells in circulation.2010
- Retraction Notice: An Outlook on Ovarian Cancer and Borderline Ovarian Tumors: Focus on Genomic and Proteomic FindingsCurrent Genomics, 2009
- Measurement of Cyclin E Genomic Copy Number and Strand Length in Cell-Free DNA Distinguish Malignant versus Benign EffusionsClinical Cancer Research, 2007
- FREE DNA IN SERUM OF CANCER-PATIENTS AND EFFECT OF THERAPY1977